Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

NSE:ADVENZYMES Statistics

Total Valuation

NSE:ADVENZYMES has a market cap or net worth of INR 31.87 billion. The enterprise value is 26.65 billion.

Market Cap	31.87B
Enterprise Value	26.65B

Important Dates

The next estimated earnings date is Friday, May 15, 2026.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

NSE:ADVENZYMES has 111.93 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class	111.93M
Shares Outstanding	111.93M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	39.67%
Owned by Institutions (%)	13.64%
Float	36.92M

Valuation Ratios

The trailing PE ratio is 20.95 and the forward PE ratio is 18.95. NSE:ADVENZYMES's PEG ratio is 1.18.

PE Ratio	20.95
Forward PE	18.95
PS Ratio	4.49
PB Ratio	2.08
P/TBV Ratio	2.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.18

Enterprise Valuation

EV / Earnings	17.50
EV / Sales	3.76
EV / EBITDA	12.99
EV / EBIT	15.53
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	0.17
Debt / FCF	n/a
Interest Coverage	59.88

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	12.79%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.23%
Revenue Per Employee	20.99M
Profits Per Employee	4.50M
Employee Count	338
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:ADVENZYMES has paid 611.09 million in taxes.

Income Tax	611.09M
Effective Tax Rate	28.27%

Stock Price Statistics

The stock price has increased by +5.78% in the last 52 weeks. The beta is 0.36, so NSE:ADVENZYMES's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	+5.78%
50-Day Moving Average	294.14
200-Day Moving Average	313.86
Relative Strength Index (RSI)	41.33
Average Volume (20 Days)	157,640

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:ADVENZYMES had revenue of INR 7.10 billion and earned 1.52 billion in profits. Earnings per share was 13.59.

Revenue	7.10B
Gross Profit	5.14B
Operating Income	1.72B
Pretax Income	2.16B
Net Income	1.52B
EBITDA	1.98B
EBIT	1.72B
Earnings Per Share (EPS)	13.59

Balance Sheet

The company has 6.06 billion in cash and 346.54 million in debt, with a net cash position of 5.71 billion or 51.02 per share.

Cash & Cash Equivalents	6.06B
Total Debt	346.54M
Net Cash	5.71B
Net Cash Per Share	51.02
Equity (Book Value)	15.34B
Book Value Per Share	132.60
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 72.44%, with operating and profit margins of 24.18% and 21.45%.

Gross Margin	72.44%
Operating Margin	24.18%
Pretax Margin	30.47%
Profit Margin	21.45%
EBITDA Margin	27.91%
EBIT Margin	24.18%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 5.20, which amounts to a dividend yield of 1.76%.

Dividend Per Share	5.20
Dividend Yield	1.76%
Dividend Growth (YoY)	1.96%
Years of Dividend Growth	5
Payout Ratio	n/a
Buyback Yield	0.01%
Shareholder Yield	1.77%
Earnings Yield	4.78%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 25, 2017. It was a forward split with a ratio of 5.

Last Split Date	May 25, 2017
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	1